MDxHealth’s prostate cancer drug gets positive medical policy from Horizon BCBS

Horizon Blue Cross Blue Shield (Horizon BCBS) of New Jersey has issued a positive medical policy for the MDxHealth’s ConfirmMDx for Prostate Cancer test.  

This is the fourth Blue Cross Blue Shield Association licensee to establish positive coverage policy and adds to the growing list of payers covering ConfirmMDx for Prostate Cancer, said the company.

“The positive coverage decision by Horizon BCBS of New Jersey further validates the clinical and economic value of ConfirmMDx for Prostate Cancer for health plans, patients and physicians,” stated Dr. Jan Groen, CEO of MDxHealth.